New strong fibrates with piperidine moiety

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Fibrates are a class of drugs used to lower lipid levels.
• There is a continuous need for novel therapeutic agents with improved efficacy and safety profiles for managing dyslipidemia and hyperglycemia.
• Piperidine and piperazine derivatives have shown promise in medicinal chemistry research.

Purpose of the Study:

• To synthesize and evaluate novel fibrate compounds incorporating piperidine, 4-hydroxypiperidine, piperidin-3-ene, and piperazine moieties.
• To identify a lead compound with superior lipid-lowering and blood glucose-lowering potential compared to existing treatments.

Main Methods:

• Synthesis of novel fibrate derivatives.
• In vivo evaluation of synthesized compounds in rodent models (mice and rats).
• Assessment of triglyceride, cholesterol, and blood sugar levels.

Main Results:

• Several new fibrate compounds were successfully synthesized.
• Compound 2-[3-[1-(4-fluorobenzoyl)-piperidin-4yl]phenoxyl-2-methylpropanoic acid (AHL-157) exhibited significant reductions in triglyceride, cholesterol, and blood sugar.
• AHL-157 demonstrated superior efficacy compared to bezafibrate in the tested animal models.

Conclusions:

• The novel fibrate derivative AHL-157 represents a promising candidate for further development.
• This compound shows potential for managing dyslipidemia and hyperglycemia.
• Structural modifications incorporating piperidine moieties can lead to potent lipid- and glucose-lowering agents.